Partek Issues Site-Wide Licenses of Partek® Genomics Suite to the NCI

Partek Incorporated has announced that it has licensed Partek Genomics Suite (Partek GS) to the National Cancer Institute (NCI).

The National Cancer Institute has purchased site-wide licenses of Partek Genomics Suite, making it available to every researcher at the NCI.

"We are extremely pleased that the National Cancer Institute has chosen Partek Genomics Suite," said Tom Downey, President of Partek Incorporated.

"It is exciting to be able to support the NCI in its goal for the diagnosis, prevention, and treatment of cancer."

Partek Genomics Suite is a statistical and visual data analysis software package that is designed to handle thousands of samples and millions of variables in a genomics experiment.

Features include detection and display of alternative splice events, exon-level and copy number alterations, and mapping sites of protein/DNA interaction in ChIP on Chip visualization within the Genome Browser, as well as import and annotation capabilities for two-color arrays.

Additionally, Partek GS is GeneChip-compatible™ and supports Affymetrix gene expression arrays, exon arrays, chromosomal copy number analysis of high-density SNP Arrays, and ChIP on Chip studies for tiling arrays.